Thursday, April 28, 2011 9:55:54 AM
7:07 am ET 04/28/2011 -
FBR Capital maintains a 'Market Perform' on Akamai Technologies (NASDAQ: AKAM), PT lowered from $44 to $40. FBR analysts says, "Last night Akamai reported a good quarter with slight upside to revenue and EPS. While the deceleration of the business was expected, the company s guidance suggests further deceleration in 2Q, which will most likely disappoint investors. We have long believed that the growth rates of 2010 were not sustainable, as they were partly driven by easy comparables from a tough 2009 and from a dramatic acceleration of traffic growth. In 2011, aside from tougher comparables, Akamai is also being adversely affected by a large number of significant deals that were reset at lower prices in 1Q and by a moderation of traffic growth." "For 2011, we trimmed our revenue and pro forma EPS estimates from $1.19 billion and $1.57 to $1.17 billion and $1.55, respectively. For 2012, we lowered our revenue and pro forma EPS estimates from $1.37 billion and $1.76 to $1.32 billion and $1.75, respectively."
Good judgment comes from experience, and a lot of that comes from bad judgment.
Recent AKAM News
- Akamai Helps Organizations Achieve Greater Security with New Zero Trust Platform • PR Newswire (US) • 04/30/2024 10:00:00 AM
- Akamai Announces 2023 Sustainability Report and Microsite • PR Newswire (US) • 04/29/2024 11:00:00 AM
- Akamai's API Security Product Achieves PCI Compliance and Sees Tremendous Customer Growth • PR Newswire (US) • 04/23/2024 10:32:00 AM
- Akamai Rolls Out Cloud Infrastructure and Services Powered by NVIDIA, Optimized for Video Processing • PR Newswire (US) • 04/15/2024 10:30:00 AM
- Akamai Technologies To Hold First Quarter 2024 Investor Conference Call On Thursday, May 9, at 4:30 PM ET • PR Newswire (US) • 04/11/2024 11:00:00 AM
- Akamai Expands Offerings in Hybrid DNS Infrastructure Security with Shield NS53 • PR Newswire (US) • 04/09/2024 10:32:00 AM
- Akamai Research Finds 29% of Web Attacks Target APIs • PR Newswire (US) • 03/19/2024 10:32:00 AM
- Akamai and Neural Magic Partner to Accelerate Deep Learning AI • PR Newswire (US) • 03/12/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:03:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 08:10:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 08:09:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 10:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:36:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:36:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:35:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:35:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:34:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:34:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:33:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:33:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:32:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:31:50 PM
- Scaleflex Joins Akamai Qualified Computing Partner Program • PR Newswire (US) • 03/07/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:49:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:48:29 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM